Point of Care CRP Testing – ICST

Point of Care CRP Testing

Step 3 and 4 of the All-Wales Acute Exacerbation of COPD Guideline focuses on the categorisation of a patient with increased sputum purulence according to point of care CRP test; not to prescribe antibiotics (<20), consider prescribing antibiotics (20-40), and prescribe antibiotics (>40).

Point of Care CRP Testing

Step 3 and 4 of the All-Wales Acute Exacerbation of COPD Guideline focuses on the categorisation of a patient with increased sputum purulence according to point of care CRP test; not to prescribe antibiotics (<20), consider prescribing antibiotics (20-40), and prescribe antibiotics (>40).

Mark as Understood

Resources

The All Wales Primary Care Management of Acute COPD Exacerbation Guideline

The All-Wales Acute Exacerbation of COPD Pathway is the first national guideline to include C-Reactive Protein (CRP) point of care testing to guide antibiotic prescribing. The aim of this guideline is to reduce overall antibiotic prescribing for patients presenting to primary care with a COPD exacerbation.

© Institute of Clinical Science and Technology (ICST) 2020

Support: admin@clinicalscience.org.uk